Cite

HARVARD Citation

    Sethi, N. et al. (2015). Direct costs of first‐generation protease inhibitors for the treatment of genotype 1 chronic hepatitis C viral infection. Journal of viral hepatitis. 22 (12), pp. 974-976. [Online]. 
  
Back to record